Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2020-01-15 Director's Dealing
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Sterna Holding AS aksjesalg
Director's Dealing Classification · 99% confidence The document text is very short (323 characters) and announces a transaction involving shares by an insider's holding company (Sterna Holding AS, owned by the Chairman/Primary Insider Christian Saure of Lifecare AS). It explicitly states the number of shares sold and the resulting ownership percentage. This directly corresponds to the definition of Director's Dealing (insider trades). Filing Type Code selected: DIRS (Director's Dealing).
2020-01-15 Norwegian
Sterna Holding AS aksjesalg
Director's Dealing Classification · 99% confidence The document text describes a transaction where Sterna Holding AS, owned by an insider (Christian Saure, Chairman of Lifecare AS), sold 250,000 shares in Lifecare AS. This is a report of personal share transactions by a company director/executive (insider trade). This directly matches the definition for Director's Dealing (DIRS). The document is very short, but its content is a specific transaction disclosure, not an announcement about the publication of a report.
2020-01-15 Norwegian
Lifecare signs joint venture to develop and digitize technologies
Regulatory Filings Classification · 99% confidence The document is titled 'STOCK EXCHANGE ANNOUNCEMENT' and details a significant corporate action: the signing of a joint venture agreement to develop and digitize medical technologies. This involves the creation of a new entity (Digital Diagnostics AG), capital infusion (NOK 75,000,000), and changes to the company's financing plans (avoiding a planned capital increase). This type of announcement, concerning fundraising, financing activities, or major structural changes related to capital, aligns best with the 'Capital/Financing Update' category. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a dividend notice (DIV). It is a specific announcement about a financing/capital structure event.
2020-01-15 English
Lifecare signs joint venture to develop and digitize technologies
M&A Activity Classification · 99% confidence The document text is very short (600 characters) and announces a specific corporate action: the signing of a joint venture (JV) to develop technology. This action involves a significant strategic partnership and the creation of a new entity, Digital Diagnostics AG. This type of announcement, which details a major transaction or strategic move that isn't a standard periodic report (like 10-K or IR) or a simple management change, often falls under broader corporate transaction categories. Since there is no specific code for 'Joint Venture Announcement', I must evaluate the closest fit. It is not an Earnings Release (ER), Director's Dealing (DIRS), or Dividend (DIV). It is a significant corporate transaction. The closest fitting categories are M&A Activity (TAR) or Capital/Financing Update (CAP). Given that a JV is a form of strategic alliance/transaction, TAR (Merger/Takeover Activity) is often used broadly for significant corporate transactions, although it is not a merger or takeover. However, since the document is an announcement of a specific, material event rather than a standard regulatory filing or report, and it doesn't fit the other specific codes, I will check the definitions again. It is not a financing event (CAP) or a share issue (SHA). Given the lack of a specific 'Strategic Alliance' code, and ruling out the others, I will default to the general Regulatory Filings (RNS) as the most appropriate fallback for a material, non-standard announcement that doesn't fit the specific transaction codes like TAR or CAP, or I must consider if it implies a change in capital structure (CAP). Since it establishes a new co-owned company, it is a significant corporate event. Given the options, and recognizing this is a material announcement, RNS is the safest fallback if it doesn't clearly map. However, if we interpret 'M&A Activity (TAR)' broadly to include significant strategic transactions like JVs that involve combining efforts or creating new entities, it could fit there. Given the strong focus on 'developing and digitizing technologies' via a new entity, it is a strategic business development. I will classify this as a general Regulatory Filing (RNS) as it is a material announcement that doesn't fit the specific transaction types like TAR (which usually implies a bid/merger) or CAP (which usually implies raising debt/equity).
2020-01-15 English
Lifecare presenterte forretningsmessig og vitenskaplig status og oppdatering
Report Publication Announcement Classification · 98% confidence The document text is very short (664 characters) and explicitly states that a presentation ('Lifecare presenterte forretningsmessig og vitenskaplig status og oppdatering') was given at an investor lunch and that the presentation itself is available via a link. This perfectly matches the 'MENU VS MEAL' rule, indicating this is an announcement about the publication of a presentation, not the presentation document itself. The closest category is Report Publication Announcement (RPA), as it announces the availability of a presentation/report. Alternatively, since it is an investor presentation, Investor Presentation (IP) could be considered, but the text structure strongly suggests an announcement of availability rather than the content of the presentation itself. Given the explicit instruction to use RPA when a document announces the publication of another report, RPA is the most appropriate classification.
2019-12-03 Norwegian
Lifecare presented business and scientific updates
Report Publication Announcement Classification · 98% confidence The document text is very short (615 characters) and explicitly states that a presentation ('Lifecare presented business and scientific updates') was given and that the presentation document itself can be found via a link or on the company homepage. This perfectly matches the 'MENU VS MEAL' rule, indicating this is an announcement about the publication of a report/presentation, not the report itself. The most appropriate category for announcing the availability of an investor presentation is 'Investor Presentation' (IP) or, if it's just an announcement of publication, 'Report Publication Announcement' (RPA). Since the content is clearly an investor presentation being announced, RPA is the most precise fit for the announcement mechanism, although IP is the underlying document type. Given the structure, RPA is chosen as it signals the publication event. If the document were the actual presentation slides, IP would be correct. Since it only points to the presentation, RPA is selected.
2019-12-03 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.